When compared to cisplatin therapy alone, the combination of FAM120A depletion with cisplatin significantly diminished the tumor growth index in GC (Fig. 7e), indicating that FAM120A depletion enhanced sensitivity to cisplatin in vivo. Here, FAM120A is linked to neoplasm.